Nanalysis Scientific (TSXV:NSCI) Debt-to-Revenue : 0.40 (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Nanalysis Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$3.60 Mil. Nanalysis Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was C$14.45 Mil. Nanalysis Scientific's annualized Revenue for the quarter that ended in Mar. 2024 was C$44.65 Mil. Nanalysis Scientific's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.40.

Nanalysis Scientific Debt-to-Revenue Historical Data

The historical data trend for Nanalysis Scientific's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Debt-to-Revenue Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.18

0.48

0.37

0.43

0.77

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial															0.74	0.67	0.64	0.56	0.40

Competitive Comparison of Nanalysis Scientific's Debt-to-Revenue

For the Scientific & Technical Instruments subindustry, Nanalysis Scientific's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanalysis Scientific's Debt-to-Revenue Distribution in the Hardware Industry

For the Hardware industry and Technology sector, Nanalysis Scientific's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanalysis Scientific's Debt-to-Revenue falls into.

Nanalysis Scientific Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Nanalysis Scientific's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(7.286	+	14.682)	/	28.466
	=	0.77

Nanalysis Scientific's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(3.601	+	14.452)	/	44.648
	=	0.40

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2024) Revenue data.

Nanalysis Scientific Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines